Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients

Clinical trial NCT07752043 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07752043
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease (SCD)Vaso-occlusive Events

Start date: 2026-09-01
Primary completion: 2030-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.